KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Inventory (2016 - 2025)

Historic Inventory for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $28.5 million.

  • Neogenomics' Inventory rose 1636.75% to $28.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 1636.75%. This contributed to the annual value of $26.7 million for FY2024, which is 1073.03% up from last year.
  • Latest data reveals that Neogenomics reported Inventory of $28.5 million as of Q3 2025, which was up 1636.75% from $34.2 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Inventory peaked at $34.2 million during Q2 2025, and registered a low of $20.3 million during Q1 2024.
  • Moreover, its 5-year median value for Inventory was $24.1 million (2023), whereas its average is $24.6 million.
  • As far as peak fluctuations go, Neogenomics' Inventory plummeted by 2076.47% in 2021, and later soared by 4720.0% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Inventory stood at $23.4 million in 2021, then rose by 3.77% to $24.3 million in 2022, then fell by 0.5% to $24.2 million in 2023, then increased by 10.73% to $26.7 million in 2024, then rose by 6.4% to $28.5 million in 2025.
  • Its Inventory was $28.5 million in Q3 2025, compared to $34.2 million in Q2 2025 and $29.8 million in Q1 2025.